Blog Search

Accelerated Access to New Treatments a “Moral Imperative” Says John Morrissey of the Schulze Family Foundation

In a powerful and thought-provoking editorial recently published on The Hill, John Morrissey – the Chair of the Scientific Advisory Board of the Richard M. Schulze Family Foundation – deemed the acceleration of access to new cancer treatments “a moral imp…
In a powerful and thought-provoking editorial recently published on The Hill, John Morrissey – the Chair of the Scientific Advisory Board of the Richard M. Schulze Family Foundati… http://mylifeisworthit.org/blog/2014/12/accelerated-access-new-treatments-moral-imperative-says-john-morrissey-schulze-family-foundation/

New Clinical Trials Demonstrate ABRAXANE®’s Efficacy in High Risk Early Breast Cancer

The German Breast Group (GBG) said ABRAXANE (nab-paclitaxel) demonstrated significant benefit for patients with early high risk breast cancer when compared to conventional chemotherapy (solvent-based paclitaxel). The findings are from the GeparSepto clini…
The German Breast Group (GBG) said ABRAXANE (nab-paclitaxel) demonstrated significant benefit for patients with early high risk breast cancer when compared to conventional chem… http://mylifeisworthit.org/blog/2014/12/new-clinical-trials-demonstrate-abraxanes-efficacy-high-risk-early-breast-cancer/

Center for Medicine in the Public Interest & Worldview Honor Top Medical Innovators in Hematology

The Center for Medicine in the Public Interest (CMPI) joined with Scientific American Worldview to recognize Worldview’s Top Medical Innovators, four scientists whose work has transformed the diagnosis and treatment of blood cancers such as leukemia, lymp…
 The Center for Medicine in the Public Interest (CMPI) joined with Scientific American Worldview to recognize Worldview’s Top Medical Innovators, four scientists whose work has tr… http://mylifeisworthit.org/blog/2014/12/center-medicine-public-interest-worldview-honor-top-medical-innovators-hematology/

National Patient Advocate Foundation: Policymakers Must Make Cancer Research a Global Priority

At the annual meeting of the American Society of Hematologists (ASH), the National Patient Advocate Foundation (NPAF) - a non-profit group dedicated representing the patient’s voice in the growing movement to improve access to quality cancer care -called …
At the annual meeting of the American Society of Hematologists (ASH), the National Patient Advocate Foundation (NPAF) – a non-profit group dedicated representing the patient’s voi… http://mylifeisworthit.org/blog/2014/12/national-patient-advocate-foundation-policymakers-must-make-cancer-research-global-priority/

« Previous 1234 Next »